Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying

Continuous manufacturing (CM) is a promising strategy to achieve various benefits in the context of quality, flexibility, safety and cost in pharmaceutical production. One of the main technical challenges of CM is that the process needs to handle transient conditions such as the start-up phase befor...

Full description

Bibliographic Details
Main Authors: Victoria Pauli, Peter Kleinebudde, Markus Krumme
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/1/67
_version_ 1828275543870537728
author Victoria Pauli
Peter Kleinebudde
Markus Krumme
author_facet Victoria Pauli
Peter Kleinebudde
Markus Krumme
author_sort Victoria Pauli
collection DOAJ
description Continuous manufacturing (CM) is a promising strategy to achieve various benefits in the context of quality, flexibility, safety and cost in pharmaceutical production. One of the main technical challenges of CM is that the process needs to handle transient conditions such as the start-up phase before state of control operation is reached, which can potentially cause out-of-specification (OOS) material. In this context, the presented paper aims to demonstrate that suitable process control strategies during start-up of a continuous granulation and drying operation can limit or even avoid OOS material production and hence can ensure that the provided benefits of CM are not compromised by poor production yields. In detail, heat-up of the drying chamber prior the start of production can lead to thermal energy being stored inside of the stainless-steel housing, acting as an energy buffer that is known to cause over-dried granules in the first few minutes of the drying process. To compensate this issue, an automatic ramping procedure of dryer rotation speed (and hence drying time) was introduced into the plant’s process control system, which counteracts the excessive drying capacity during start-up. As a result, dry granules exiting the dryer complied with the targeted intermediate critical quality attribute loss-on-drying (LOD) from the very beginning of production.
first_indexed 2024-04-13T06:48:11Z
format Article
id doaj.art-2835c5c9d4c5498e91687c17a71d9980
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-13T06:48:11Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-2835c5c9d4c5498e91687c17a71d99802022-12-22T02:57:29ZengMDPI AGPharmaceutics1999-49232020-01-011216710.3390/pharmaceutics12010067pharmaceutics12010067Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and DryingVictoria Pauli0Peter Kleinebudde1Markus Krumme2Novartis Pharma AG, Continuous Manufacturing (CM) Unit, Novartis Campus, 4002 Basel, SwitzerlandInstitute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitaetsstr. 1, 40225 Dusseldorf, GermanyNovartis Pharma AG, Continuous Manufacturing (CM) Unit, Novartis Campus, 4002 Basel, SwitzerlandContinuous manufacturing (CM) is a promising strategy to achieve various benefits in the context of quality, flexibility, safety and cost in pharmaceutical production. One of the main technical challenges of CM is that the process needs to handle transient conditions such as the start-up phase before state of control operation is reached, which can potentially cause out-of-specification (OOS) material. In this context, the presented paper aims to demonstrate that suitable process control strategies during start-up of a continuous granulation and drying operation can limit or even avoid OOS material production and hence can ensure that the provided benefits of CM are not compromised by poor production yields. In detail, heat-up of the drying chamber prior the start of production can lead to thermal energy being stored inside of the stainless-steel housing, acting as an energy buffer that is known to cause over-dried granules in the first few minutes of the drying process. To compensate this issue, an automatic ramping procedure of dryer rotation speed (and hence drying time) was introduced into the plant’s process control system, which counteracts the excessive drying capacity during start-up. As a result, dry granules exiting the dryer complied with the targeted intermediate critical quality attribute loss-on-drying (LOD) from the very beginning of production.https://www.mdpi.com/1999-4923/12/1/67continuous manufacturingprocess controlmodel-based controlstart-upshut-downcost reduction
spellingShingle Victoria Pauli
Peter Kleinebudde
Markus Krumme
Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
Pharmaceutics
continuous manufacturing
process control
model-based control
start-up
shut-down
cost reduction
title Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_full Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_fullStr Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_full_unstemmed Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_short Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_sort predictive model based process start up in pharmaceutical continuous granulation and drying
topic continuous manufacturing
process control
model-based control
start-up
shut-down
cost reduction
url https://www.mdpi.com/1999-4923/12/1/67
work_keys_str_mv AT victoriapauli predictivemodelbasedprocessstartupinpharmaceuticalcontinuousgranulationanddrying
AT peterkleinebudde predictivemodelbasedprocessstartupinpharmaceuticalcontinuousgranulationanddrying
AT markuskrumme predictivemodelbasedprocessstartupinpharmaceuticalcontinuousgranulationanddrying